• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定一个新的 PANoptosis 相关基因特征,用于预测透明细胞肾细胞癌的预后。

Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma.

机构信息

Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Department of Urology, Shanxian Central Hospital, Heze, Shandong, China.

出版信息

Medicine (Baltimore). 2024 Sep 27;103(39):e39874. doi: 10.1097/MD.0000000000039874.

DOI:10.1097/MD.0000000000039874
PMID:39331898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11441883/
Abstract

PANoptosis has been shown to play an important role in tumorigenesis and gain more attention. Yet, the prognostic significance of PANoptosis-related genes has not been investigated more in clear cell renal cell carcinoma (ccRCC). The aim of this research was designed to identify and create a signature of PANoptosis-related genes which was expected to predict prognosis of ccRCC more effectively. The transcriptome data and clinical information were collected from The Cancer Genome Atlas database and the Gene Expression Omnibus database. Optimal differentially expressed PANoptosis-related genes, which were closely associated with prognosis and employed to construct a risk score, were extracted by univariate Cox analysis, least absolute shrinkage and selection operator Cox regression and multivariate Cox analysis. We performed Kaplan-Meier survival analysis and time-dependent receiver operating characteristic curves to complete this process. By adopting univariate and multivariate analysis, the constructed risk score was assessed to verify whether it could be taken as an independent contributor for prognosis. Moreover, we created a nomogram in order to predict overall survival (OS) of ccRCC. Five differentially expressed PANoptosis-related genes were screened out and used to construct a risk score. Our results showed that ccRCC patients with high risk score had a poor prognosis and shorter OS. The results of Kaplan-Meier curves and the area under the receiver operating characteristic curves of 1-, 3-, and 5-year OS indicated that the prediction performance was satisfactory. Additionally, the risk model could be taken as an independent prognostic factor in training and validation cohorts. The nomogram exhibited excellent reliability in predicting OS, which was validated by calibration curves. We identified 5 PANoptosis-related genes, which were used to construct a risk score and a nomogram for prognostic prediction with reliable predictive capability. The present study may provide new potential therapeutic targets and precise treatment strategies for ccRCC.

摘要

细胞焦亡与肿瘤的发生发展密切相关,受到越来越多的关注。然而,细胞焦亡相关基因在透明细胞肾细胞癌(ccRCC)中的预后意义尚不清楚。本研究旨在鉴定和构建一个细胞焦亡相关基因特征,以期更有效地预测 ccRCC 的预后。从癌症基因组图谱(TCGA)数据库和基因表达综合数据库(GEO)中收集转录组数据和临床信息。通过单因素 Cox 分析、最小绝对收缩和选择算子 Cox 回归和多因素 Cox 分析,提取与预后密切相关并用于构建风险评分的最佳差异表达的细胞焦亡相关基因。我们进行 Kaplan-Meier 生存分析和时间依赖的受试者工作特征曲线来完成这个过程。通过采用单因素和多因素分析,评估构建的风险评分是否可以作为独立的预后因素。此外,我们创建了一个列线图,以预测 ccRCC 的总生存期(OS)。筛选出 5 个差异表达的细胞焦亡相关基因,用于构建风险评分。结果表明,风险评分高的 ccRCC 患者预后不良,OS 更短。Kaplan-Meier 曲线和 1、3、5 年 OS 的受试者工作特征曲线下面积的结果表明,预测性能令人满意。此外,该风险模型可作为训练和验证队列中独立的预后因素。列线图在预测 OS 方面表现出良好的可靠性,校准曲线也验证了这一点。我们确定了 5 个细胞焦亡相关基因,用于构建风险评分和列线图,以进行具有可靠预测能力的预后预测。本研究可能为 ccRCC 提供新的潜在治疗靶点和精确的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/854a6202d3c1/medi-103-e39874-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/7ec1712a5125/medi-103-e39874-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/711dc7a6695f/medi-103-e39874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/54e988893f9d/medi-103-e39874-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/3be8360caf2d/medi-103-e39874-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/60994ec44a9e/medi-103-e39874-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/7df19efb8458/medi-103-e39874-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/cad81e724042/medi-103-e39874-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/b41db92f8f94/medi-103-e39874-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/34da1bd67607/medi-103-e39874-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/854a6202d3c1/medi-103-e39874-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/7ec1712a5125/medi-103-e39874-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/711dc7a6695f/medi-103-e39874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/54e988893f9d/medi-103-e39874-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/3be8360caf2d/medi-103-e39874-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/60994ec44a9e/medi-103-e39874-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/7df19efb8458/medi-103-e39874-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/cad81e724042/medi-103-e39874-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/b41db92f8f94/medi-103-e39874-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/34da1bd67607/medi-103-e39874-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1a/11441883/854a6202d3c1/medi-103-e39874-g010.jpg

相似文献

1
Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma.鉴定一个新的 PANoptosis 相关基因特征,用于预测透明细胞肾细胞癌的预后。
Medicine (Baltimore). 2024 Sep 27;103(39):e39874. doi: 10.1097/MD.0000000000039874.
2
A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.一种新型的 10 个糖酵解相关基因特征可预测透明细胞肾细胞癌的总生存期。
BMC Cancer. 2021 Apr 9;21(1):381. doi: 10.1186/s12885-021-08111-0.
3
Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients.识别和验证透明细胞肾细胞癌患者中与缺氧相关的预后特征。
Medicine (Baltimore). 2021 Oct 1;100(39):e27374. doi: 10.1097/MD.0000000000027374.
4
Identification of a PANoptosis-related long noncoding rna risk signature for prognosis and immunology in colon adenocarcinoma.鉴定一种与全凋亡相关的长链非编码RNA风险特征用于预测结肠腺癌的预后和免疫情况
BMC Cancer. 2025 Apr 10;25(1):662. doi: 10.1186/s12885-025-14021-2.
5
Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma.与酪氨酸激酶抑制剂耐药相关的6基因特征鉴定:透明细胞肾细胞癌的预后
Med Sci Monit. 2020 Dec 9;26:e927078. doi: 10.12659/MSM.927078.
6
Transcriptome analysis revealed a novel nine-gene prognostic risk score of clear cell renal cell carcinoma.转录组分析揭示了透明细胞肾细胞癌的一个新的九基因预后风险评分。
Medicine (Baltimore). 2024 Sep 27;103(39):e39678. doi: 10.1097/MD.0000000000039678.
7
Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.基于总体生存相关基因表达的风险特征谱及其在透明细胞肾细胞癌中的预后意义。
Biosci Rep. 2020 Sep 30;40(9). doi: 10.1042/BSR20200492.
8
Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.通过转录组学鉴定透明细胞肾细胞癌(ccRCC)的预后生物标志物。
Ann Clin Lab Sci. 2021 Sep;51(5):597-608.
9
Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma.基于 RNA 结合蛋白相关基因分析的透明细胞肾细胞癌预后标志物的研究。
Aging (Albany NY). 2021 Jan 10;13(3):3926-3944. doi: 10.18632/aging.202360.
10
Construction and validation of a survival prognostic model for clear cell renal cell carcinoma.透明细胞肾细胞癌生存预后模型的构建与验证
Clin Nephrol. 2025 Mar;103(3):200-212. doi: 10.5414/CN111509.

本文引用的文献

1
The Role of MUC1 in Renal Cell Carcinoma.MUC1 在肾细胞癌中的作用。
Biomolecules. 2024 Mar 7;14(3):315. doi: 10.3390/biom14030315.
2
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma.补体系统与肾脏:在肾脏疾病、肾移植和肾细胞癌中的作用。
Int J Mol Sci. 2023 Nov 20;24(22):16515. doi: 10.3390/ijms242216515.
3
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers.肾细胞癌中的癌症干细胞:起源和生物标志物。
Int J Mol Sci. 2023 Aug 24;24(17):13179. doi: 10.3390/ijms241713179.
4
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma.肾细胞癌肿瘤微环境中的细胞与分子参与者
J Clin Med. 2023 Jun 7;12(12):3888. doi: 10.3390/jcm12123888.
5
Mitochondrial dysfunctions induce PANoptosis and ferroptosis in cerebral ischemia/reperfusion injury: from pathology to therapeutic potential.线粒体功能障碍在脑缺血/再灌注损伤中诱导PAN凋亡和铁死亡:从病理到治疗潜力
Front Cell Neurosci. 2023 May 24;17:1191629. doi: 10.3389/fncel.2023.1191629. eCollection 2023.
6
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice.肾细胞癌中的免疫检查点抑制剂:其在临床实践中应用的分子基础和原理
Biomedicines. 2023 Apr 2;11(4):1071. doi: 10.3390/biomedicines11041071.
7
PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis.全程序性坏死:一种以焦亡、凋亡和坏死性凋亡为特征的细胞死亡。
J Inflamm Res. 2023 Apr 12;16:1523-1532. doi: 10.2147/JIR.S403819. eCollection 2023.
8
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery.脂质代谢在前列腺癌和肾癌中的阴暗面:分子诊断和生物标志物发现的新见解。
Expert Rev Mol Diagn. 2023 Apr;23(4):297-313. doi: 10.1080/14737159.2023.2195553. Epub 2023 Mar 28.
9
Molecular subtypes based on PANoptosis-related genes and tumor microenvironment infiltration characteristics in lower-grade glioma.基于 PANoptosis 相关基因和肿瘤微环境浸润特征的低级别胶质瘤分子亚型。
Funct Integr Genomics. 2023 Mar 17;23(2):84. doi: 10.1007/s10142-023-01003-5.
10
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation.MUC1 表达通过补体系统激活和免疫浸润调节影响肾细胞癌微环境中的免疫炎症反应。
Int J Mol Sci. 2023 Mar 2;24(5):4814. doi: 10.3390/ijms24054814.